Prostamax is a bioengineered active peptide designed for treating various prostate diseases.
Developed through extensive molecular-level research into the pathological mechanisms of these disorders, it incorporates partial sequences from specific growth factors, anti-inflammatory peptides, or signal-modulating peptides.
Amino acid substitutions, sequence truncation, and cyclization are used to enhance its stability, bioavailability, and targeting; reduction in degradation and consequently a prolonged half-life are direct outcomes of this process.
Specific action on prostate tissue is achieved.
Overall, Prostamax represents a multi-mechanism, synergistic bioactive solution to improving male prostate physiological health.
序列
Lys-Glu-Asp-Pro
化学文摘社编号
/
分子式
C20H33N5O9
分子量
487.51
Research Of Prostamax Peptide
1.Mechanisms of Action and Therapeutic Effects
Inhibiting key inflammatory signaling pathways within the prostate itself is one of its primary modes of operation – critical inflammatory factors exhibit significantly suppressed expression.
Effective alleviation of all forms of inflammatory conditions, associated swelling and subsequent pain, ensue.
Modulation of androgen receptor signaling (or direct influence on 5α-reductase activity) regulates DHT (Dihydrotestosterone) production (the more potent form of testosterone) and effectively controls epithelial cell proliferation.
Excessive proliferation caused by unregulated DHT is thus inhibited, lower urinary tract symptoms (LUTS) being a direct result of prostate enlargement.
Studies have also indicated significant potential for Prostamax in promoting apoptosis of prostate cells, angiogenesis inhibition, and comprehensive antioxidant/anti-inflammatory defense mechanisms.
2.Regulating Hormonal Pathways
As mentioned above, the conversion of testosterone to DHT is pivotal to its action.
Aberrant proliferation is significantly reversed by this process.
3.Anti-inflammatory and Antioxidant Effects
The aforementioned inflammatory and oxidative damage is mitigated.
4.Anti-Proliferative Function
Cell cycle arrest (G1 phase) is a demonstrated effect of Prostamax treatment, and as a result of all the above, a restored physiological state of the prostate can be achieved.
Pressure on the urethra and bladder, and associated symptoms of chronic disease, are relieved.
COA
高效液相色谱法
MS
